Medicine

Medicine

Focused Ultrasound Trial Targets Schizophrenia Hallucinations at UCSF

Psychiatrists at the University of California San Francisco have started a first-in-human trial using low-intensity focused ultrasound to suppress auditory hallucinations in patients with schizophrenia. The study tests whether acoustic pulses delivered through the skull can alter deep brain activity without surgery. More than 70 percent of people with schizophrenia hear voices, and about 40 percent do not find relief through antipsychotic drugs.

Medicine

Activating p53 Protein Boosts Engineered T Cells Against Cancer

Scientists at the UCLA Health Jonsson Comprehensive Cancer Center have found that temporarily activating the tumor-suppressor protein p53 improves the stamina and killing power of engineered immune cells. The study, published in Frontiers in Immunology, demonstrates that dosing human T cells with the investigational drug navtemadlin during laboratory preparation keeps them from exhausting quickly and enhances their ability to destroy melanoma cells.

Letizia Giugliano

Medicine

Switching Off TET2 Turns Radiation-Triggered Immune Cells Against Tumours

Radiation therapy kills cancer cells by damaging their DNA, yet it can also trigger the bone marrow to produce suppressor cells that protect surviving tumours. A research team at the University of Chicago has discovered that inhibiting an enzyme called TET2 reverses this effect, providing an epigenetic innovation that helps radiation and immunotherapy shrink lesions and curb metastasis. Their study, published in Cancer Cell, demonstrates the mechanism in clinical samples and animal models.

Giovanni Sapere

Medicine

Hong Kong PolyU Develops MRI Biomarker to Predict Breast Cancer Drug Response

Researchers at The Hong Kong Polytechnic University have introduced a medical innovation that predicts how breast cancer patients will respond to targeted therapy before treatment starts. Using advanced radiomics on routine magnetic resonance scans, the team developed an imaging biomarker called the Tumour Heterogeneity Index. The method identifies patients likely to respond to AKT inhibitors, sparing others from ineffective treatments and toxic side effects.

Letizia Giugliano

Medicine

Ten Blood Markers Predict Aging Health and Cardiometabolic Disease Risk

Researchers at Leiden University Medical Center and the Max Planck Institute for Biology of Aging have developed a personalized metabolic score that evaluates disease risk and healthy aging. Presented at the FAPESP Week Netherlands conference, the innovation analyzes ten routine blood substances to generate a single profile of metabolic health. A one-point rise on the inverted scale corresponds to an average 14-year delay in the onset of cardiometabolic conditions.

Giovanni Sapere

Medicine

Microfluidic chip screens leukemia drug therapies in children

Engineers and pediatric oncologists at Emory University, Children's Healthcare of Atlanta, and Georgia Tech have developed a diagnostic test that screens cancer drugs directly against patient cells at diagnosis. The platform evaluates how three-drug combinations at varying doses affect live cancer cells, offering immediate functional data from a single sample.

Giovanni Sapere

Medicine

Merck and Moderna mRNA Vaccine Slashes Melanoma Recurrence Risk

A collaborative medical innovation from pharmaceutical developers has demonstrated that an mRNA therapeutic can substantially reduce the likelihood of skin cancer recurrence. According to reporting published by Science, the treatment developed by Merck and Moderna successfully curtails melanoma returns, though researchers still face unresolved questions regarding its exact mechanism.

Giovanni Sapere

Medicine

Fraunhofer IDMT Develops Wearable trEEGrid Patch for 24-Hour EEG Monitoring

Researchers at the Fraunhofer Institute for Digital Media Technology IDMT have validated a flexible electrode patch capable of recording stable brain activity over a continuous 24-hour period. The study, published in the journal Sensors, demonstrates that the wearable system functions reliably during routine daytime tasks and natural sleep. This invention provides a practical method for long-term neurological monitoring in everyday environments.

Letizia Giugliano

Medicine

Silver Diamine Fluoride Halts Childhood Cavities Without Drilling

A major multi-site clinical trial led by researchers at the University of Michigan has confirmed that painting teeth with silver diamine fluoride can arrest tooth decay in young children without drilling, injections, or sedation. The clinical discovery, published in JAMA Pediatrics, offers a low-cost medical innovation that could prevent severe dental pain and hospital surgeries for thousands of pediatric patients.

Giovanni Sapere

Medicine

From Prototype to Deployment: The Regulatory and Engineering Barriers in Health Innovation

Navigating the pathway from laboratory concept to working deployment presents significant friction for healthcare and technology creators. On October 21, 2026, an editorial analysis published by Interesting Engineering outlined how emerging technical work in health and engineering often stumbles not on theoretical merit, but on integration, regulation, and supply chain constraints. Addressing these friction points is essential for every inventor seeking to move biomedical designs into standard clinical practice.

Letizia Giugliano

Medicine

Personalized mRNA Melanoma Vaccine Cuts Recurrence Risk by 42%

In an international Phase III trial, adding the personalized therapeutic vaccine intismeran to pembrolizumab immunotherapy reduced the risk of recurrence or death by 42% in high-risk melanoma patients after surgery. Presented at the ESMO Congress 2026, the findings establish a new therapeutic approach combining tailored neoantigen targeting with immune checkpoint blockade. This medical innovation offers post-surgical protection for patients facing high chances of cancer relapse.

Giovanni Sapere

Medicine

UNC Researchers Uncover Protein Pathway Shielding Dormant HIV

Scientists at the University of North Carolina at Chapel Hill School of Medicine have identified a human protein pathway responsible for keeping HIV dormant within host cells. Published in Cell Reports on October 24, 2026, the discovery exposes how viral reservoirs persist in blood and brain immune cells despite antiretroviral therapy. Uncovering these cellular mechanisms provides a scientific foundation for therapeutic strategies designed to expose and eradicate persistent virus.

Giovanni Sapere

Medicine

3D-Printed Nitinol Braids Advance Custom Cardiovascular Implants

A research team led by the IMDEA Materials Institute and Universidad Politécnica de Madrid has developed an invention for manufacturing personalized cardiovascular implants using 3D printing and superelastic nitinol. Published in npj Metamaterials, the method enables single-step production of flexible braided structures that compress into delivery catheters without structural failure, as reported by [MedicalXpress](https://medicalxpress.com/news/2026-10-3d-method-options-personalized-cardiovascular.html).

Giovanni Sapere

Medicine

Subcortical Nuclei Anticipate Sensory Sights and Touch in Real Time

Neurobiological research reported in mid-October 2026 demonstrates that subcortical nuclei anticipate sensory experiences prior to their physical occurrence. The discovery provides fresh insight into sensory processing and neurological timing mechanisms. Understanding how subcortical regions prepare for incoming stimuli highlights an important scientific innovation in basic sensory medicine.

Letizia Giugliano

Medicine

Global Study Shows Rising Acne Burden Through 2050

A cross-sectional study led by Brigham and Women's Hospital reveals that the global burden of acne vulgaris increased substantially between 1990 and 2023 and will continue expanding through 2050. Published in JAMA Dermatology, the findings underscore how skin conditions generate extensive morbidity, accelerating the demand for clinical innovation across global healthcare systems.

Giovanni Sapere

Medicine

Building a Daily Walking Habit: Step Targets and Preventive Health Evidence

Public health researchers emphasize that establishing a regular walking routine requires minimal equipment while delivering measurable cardiovascular benefits. Research led by kinesiologist Amanda Paluch at the University of Massachusetts Amherst highlights how structured, incremental increases in daily steps can lower premature death and stroke risks. Incorporating accessible tracking tools allows individuals to monitor baseline activity and build sustainable long-term movement habits.

Letizia Giugliano

Medicine

Optogenetics Pioneers Win Nobel Prize for Illuminating the Brain

Karl Deisseroth, Peter Hegemann, and Georg Nagel have been awarded the Nobel Prize in Physiology or Medicine 2026 for their foundational work in optogenetics. This revolutionary technique utilizes light to control nerve cells, offering unprecedented insight into how the brain forms memories, emotions, and behaviors, and paving the way for new treatments for neurological conditions.

Giovanni Sapere

Medicine

Nanorobots: What it is and how it works

Nanorobots are nanoscale devices designed to perform specific tasks within the human body, such as targeted drug delivery, repairing damaged tissue, or eliminating cancer cells. Thanks to their extremely small size, nanorobots can navigate through the circulatory system and directly penetrate…

Mattia Sapere